COMMUNIQUÉS West-GlobeNewswire

Kura Oncology to Present at Bank of America Merrill Lynch Health Care Conference
08/05/2019
SAN DIEGO, May 08, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that Troy Wilson [...]
Progressive Care to Host Conference Call on the 2019 Quarterly Filing and Business Update on May 15th, 2019
08/05/2019
MIAMI, May 08, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call [...]
Daré Bioscience Announces the Publication of a Pharmacokinetics Study of DARE-FRT1, a Potential Therapy for Preterm Birth and Fertility, in Drug Delivery and Translational Research
08/05/2019
SAN DIEGO, May 08, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women’s health innovation, today announced the article entitled “Pharmacokinetics and tolerability of a novel progesterone [...]
CymaBay Therapeutics Announces Multiple Presentations at DDW 2019
08/05/2019
NEWARK, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced that multiple abstracts related to its seladelpar clinical development program for the treatment of primary [...]
PSIQ to Acquire 80% of Ecoland Including Multiple Cannabis Licenses, Operations and Real Estate for Approximately $18,300,000
08/05/2019
SUNRISE, Fla., May 08, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce the proposed acquisition of 80% of the Capital Stock and Assets of Ecoland K.K.L. LTD, an Israel LTD. and [...]
C-RAD AB – Interim report January-March 2019
08/05/2019
C-RAD AB – Interim report January-March 2019 REVENUE INCREASE OF 40 PERCENT JANUARY - MARCH 2019 Revenues: 47.3 (33.8) MSEK Order intake: 47.8 (50.6) MSEK EBITDA: 3.6 (-3.6) MSEK Operating profit: 1.2 (-4.7) MSEK Net [...]
Oxurion NV : Oxurion NV Business Update - Q1 2019
08/05/2019
Oxurion NV Business Update - Q1 2019 Significant Progress with Novel Clinical Diabetic Eye Disease Portfolio Enrollment of THR-317 Phase 2 Combination Study & THR-149 Phase 1 Study Completed Ahead of Schedule First [...]
PCI Biotech: First quarter 2019 results
08/05/2019
Oslo (Norway), 8 May 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announces its first quarter 2019 result. Please find enclosed the report and presentation. First sites for the [...]
Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT
08/05/2019
HIGHLIGHTS Revenue reached DKK 4,234 million in the first quarter of 2019 representing a decline of 8% (6% in local currencies) compared to the same period last year. The decline was expected and a result of generic [...]
Novartis data at AAN show Mayzent's® positive impact on cognitive processing speed, a core element of cognitive function, in people living with secondary progressive MS
08/05/2019
Data from EXPAND - the largest randomized controlled trial in a representative secondary progressive MS (SPMS) population - show Mayzent ® (siponimod) had a meaningful benefit on cognitive processing speed (CPS) for [...]
Addex to Present at the 28th Medtech Investing Europe Conference
08/05/2019
Geneva, Switzerland, May 8, 2019 – Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that CEO, Tim Dyer will give a corporate [...]
IBA Déclaration Intermédiaire – Premier Trimestre 2019
08/05/2019
Louvain-la-Neuve, Belgique, le 8 mai 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, publie aujourd’hui une revue de ses activités au [...]
IBA BUSINESS UPDATE – FIRST QUARTER 2019
08/05/2019
Louvain-La-Neuve, Belgium, 8 May 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces its business update for the first [...]
MediciNova Participated in the RECEDE Phase 3 Degenerative Cervical Myelopathy Trial Kick-off Meeting, DCM Symposium and the Official Launch of Myelopathy.org in London, United Kingdom
08/05/2019
Dr. Yuichi Iwaki, M.D., Ph.D., President and Chief Executive Officer, invited speaker at the official launch of Myelopathy.org at The British Parliament House of Lords, shared his thoughts on supporting innovative [...]
TOWER ONE Cease Trade Order Due to Late Financial Statements
08/05/2019
VANCOUVER, British Columbia, May 07, 2019 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announces that a cease trade order has been issued against [...]
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
07/05/2019
Company Release no. 09/2019 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 07 May 2019 Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program Today, the Board of Directors of Veloxis Pharmaceuticals [...]
Aeterna Zentaris Reports First Quarter 2019 Financial and Operating Results
07/05/2019
CHARLESTON, S.C., May 07, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the first quarter ended March 31, 2019. All Amounts are in U.S. [...]
Supernus Announces First Quarter 2019 Financial Results
07/05/2019
Total revenue of $85.5 million and net product sales of $83.1 million. Net product sales compare to $89.1 million in 2018 and were adversely impacted by approximately $10 million in channel inventory reduction in the [...]
National Research Corporation Announces First Quarter 2019 Results
07/05/2019
LINCOLN, Neb., May 07, 2019 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ: NRC) today announced results for the first quarter of 2019. Net New Sales of $4.1 million Net Income increased to $8.2 million 650+ [...]

Pages